{"title":"法律程序:介绍证人。","authors":"Emanuele Nicastri","doi":"10.1080/03008870310009731","DOIUrl":null,"url":null,"abstract":"For the purposes of this proceeding, either the witness for defence or the plaintiff will discuss the strength and the level of each single indication for the use of genotypic assays for the detection of antiretroviral resistance. The witnesses will consider the peer-reviewed medical literature and the experts’ opinions expressed during international scientific congresses to promote or not to promote the use of genotypic assays.","PeriodicalId":76520,"journal":{"name":"Scandinavian journal of infectious diseases. Supplementum","volume":"106 ","pages":"58-60"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03008870310009731","citationCount":"0","resultStr":"{\"title\":\"The legal proceeding: introduction of the witnesses.\",\"authors\":\"Emanuele Nicastri\",\"doi\":\"10.1080/03008870310009731\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"For the purposes of this proceeding, either the witness for defence or the plaintiff will discuss the strength and the level of each single indication for the use of genotypic assays for the detection of antiretroviral resistance. The witnesses will consider the peer-reviewed medical literature and the experts’ opinions expressed during international scientific congresses to promote or not to promote the use of genotypic assays.\",\"PeriodicalId\":76520,\"journal\":{\"name\":\"Scandinavian journal of infectious diseases. Supplementum\",\"volume\":\"106 \",\"pages\":\"58-60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/03008870310009731\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian journal of infectious diseases. Supplementum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/03008870310009731\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian journal of infectious diseases. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/03008870310009731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The legal proceeding: introduction of the witnesses.
For the purposes of this proceeding, either the witness for defence or the plaintiff will discuss the strength and the level of each single indication for the use of genotypic assays for the detection of antiretroviral resistance. The witnesses will consider the peer-reviewed medical literature and the experts’ opinions expressed during international scientific congresses to promote or not to promote the use of genotypic assays.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
